Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.710
+0.140 (5.45%)
Jun 2, 2026, 1:45 PM EDT - Market open
Fortress Biotech Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Fortress Biotech stock has a consensus rating of "Strong Buy" and an average price target of $11. The average 1-year stock price forecast is 305.90% higher than the current stock price, while the lowest is $5.00 (+84.50%) and the highest is $17 (+527.31%).
Price Target: $11 (+305.90%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Fortress Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $4.5 → $5 | Buy | Maintains | $4.5 → $5 | +84.50% | May 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $17 | Buy | Reiterates | $17 | +527.31% | Feb 23, 2026 |
Financial Forecast
Revenue This Year
79.88M
from 63.26M
Increased by 26.26%
Revenue Next Year
134.15M
from 79.88M
Increased by 67.95%
EPS This Year
2.40
from -0.07
EPS Next Year
0.51
from 2.40
Decreased by -78.96%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 79.9M | ||
| Avg | 79.9M | ||
| Low | 79.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.3% | ||
| Avg | 26.3% | ||
| Low | 26.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.40 | ||
| Avg | 2.40 | ||
| Low | 2.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.